Obesity - Management Strategies Flashcards

1
Q

Behavioual

A

Self-monitoring
Stimulus control
Cognitive restructuring
Social support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Behavioural:

Self monitoring

A

Technology
Immediate feedback
Understand lifestyle choices helpful or harmful
Observe + record - eating, exercise, emotions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Behavioural:

Stimulus control

A
Eat at table
Smaller plates
Eat same time + place
Healthy snacks available
Shoes in place to remind
Don’t buy tempting foods
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Behavioural:

Cognitive restruction

A
Cognitive behavioural therapy
Helps stop negative cycles
Replace all or nothing with realistic ideas
Self-efficacy
Mindful eating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Behavioural:

Social support

A

Family, friends

Commercial slimming groups - peer to peer, dynamic, regular contact, learn from others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dietary

A
Recommendations
Moderate deficit diet
Meal replacements
Very low calorie diet
Considerations
2-day diet
Monitoring
Menu planning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dietary:

Recommendations

A

2000kcal/day
Protein = 15%
Fat = 35%
CHO = 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Moderate deficit diet

A

Intake restricted
Usually 600kcal -> -0.5kg/wk
Weight loss continuing up to 3yr period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Meal replacements

A

Calorie controlled
Higher weight-loss at 3 months + 1yr (compared to trad diets)

Disadvantages

  • not sustainable
  • limited flavours/lack variety
  • lower satiety
  • no behaviour change
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Very low calorie diet

A
Liquid based
Reduce fat + CHO
<800kcal/d
Loss 1.5-2.5kg/wk
Max 12 weeks
BMI >30
High drop out rate + regain weight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dietary considerations

A

Tailor to individual
Fad diets
Change not diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2-day diet

A
Low CHO x2days
Healthy eating x5days
Greater fat loss
Intermitted energy restriction
Decreased insulin + inflammatory markers (linked to CVD + diabetes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dietary

Monitoring

A

Phases

Regular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dietary

menu planning

A

Preferences
Variety
Organised shopping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Physical activity

A
Benefits
Barriers
Early years
Adults
Older
Obesity prevention
Health at every size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Physical activity

Barriers

A

Low energy level

Motivation

17
Q

Physical activity

Benefits

A

Social
Strengthen body
Prevent major diseases

18
Q

Physical activity

Early years

A

Encouraged from birth
Pre-school = 3hrs/day
<5yrs = minimise sedentary for long periods

19
Q

Physical activity

Adults

A

2 1/2 hours / week
75mins high intensity
Strength 2x week

20
Q

Physical activity

Older adults

A

Any P.A is of benefit
Active daily
Activity that improves balance + coordination

21
Q

Physical activity

Obesity prevention

A

45-60 mins/day

Previously obese = 60-90 min/day

22
Q

Physical activity

Health at every size

A

Acceptance + healthy lifestyle without dieting
Promotes + attitudes

May never result in weight loss so no decrease disease risk
Promotes ‘not my fault’ thinking

23
Q

Pharmacological

A
Human drug trials
Suppress appetite
Affecting EE
Nutrient partitioning
Obesity drugs
24
Q

Pharmacological:

Human drug trials

A

Phase 1 - tolerability
Phase 2 - proof concept
Phase 3 - large scale multi-centre trials
Phase 4 - long term monitoring

25
Q

Pharmacological:

Drugs suppress appetite

A

Sympathomimetics - mimic effect of neurotransmitters of PNS

Noradrenergic - phenteramine (release + block norE uptake)

Serotonergic - fluoxetine (serotonin release)

Combo of N + S

Subitramine - antidepressant re-marketed

Phytocannabinoid antagonists

26
Q

Pharmacological:

Affecting EE

A

B-3 adrenergic agonists

Ephedrine - stimulates norA secretion

27
Q

Pharmacological:

Drugs affecting nutrient partitioning

A

Glucagon-like peptide-1

Orlistat - behaviour change (side effects), reduces fat absorption, BMI >28 with risk factors or BMI >30

Alli - OTC orlistat

28
Q

Pharmacological:

Obesity drugs

A

XLS medical - fibre binds with fat preventing absorption, otc

Ideal - orally active, few side effects, visceral fat decrease, non-toxic, long acting

Others available - fibre pills, diuretics, laxatives, tapeworm pills

Some consider drugs ‘medicalise unhealthy lifestyle’